全文获取类型
收费全文 | 5268篇 |
免费 | 419篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 102篇 |
儿科学 | 231篇 |
妇产科学 | 83篇 |
基础医学 | 719篇 |
口腔科学 | 72篇 |
临床医学 | 427篇 |
内科学 | 1123篇 |
皮肤病学 | 135篇 |
神经病学 | 288篇 |
特种医学 | 153篇 |
外科学 | 615篇 |
综合类 | 317篇 |
一般理论 | 4篇 |
预防医学 | 333篇 |
眼科学 | 82篇 |
药学 | 425篇 |
中国医学 | 30篇 |
肿瘤学 | 562篇 |
出版年
2023年 | 26篇 |
2022年 | 61篇 |
2021年 | 121篇 |
2020年 | 68篇 |
2019年 | 98篇 |
2018年 | 127篇 |
2017年 | 79篇 |
2016年 | 115篇 |
2015年 | 123篇 |
2014年 | 163篇 |
2013年 | 203篇 |
2012年 | 353篇 |
2011年 | 340篇 |
2010年 | 197篇 |
2009年 | 171篇 |
2008年 | 278篇 |
2007年 | 304篇 |
2006年 | 217篇 |
2005年 | 192篇 |
2004年 | 192篇 |
2003年 | 178篇 |
2002年 | 147篇 |
2001年 | 159篇 |
2000年 | 163篇 |
1999年 | 157篇 |
1998年 | 65篇 |
1997年 | 51篇 |
1996年 | 44篇 |
1995年 | 44篇 |
1994年 | 49篇 |
1993年 | 37篇 |
1992年 | 118篇 |
1991年 | 81篇 |
1990年 | 76篇 |
1989年 | 98篇 |
1988年 | 53篇 |
1987年 | 64篇 |
1986年 | 51篇 |
1985年 | 56篇 |
1984年 | 34篇 |
1983年 | 27篇 |
1982年 | 28篇 |
1979年 | 27篇 |
1977年 | 43篇 |
1976年 | 25篇 |
1974年 | 32篇 |
1973年 | 41篇 |
1972年 | 34篇 |
1971年 | 29篇 |
1967年 | 33篇 |
排序方式: 共有5701条查询结果,搜索用时 46 毫秒
131.
132.
V. A. Arankalle J. Jha M. O. Favorov A. Chaudhari H. A. Fields K. Banerjee 《Journal of viral hepatitis》1995,2(4):189-193
Summary. During 1990, 38 patients with fulminant non-A, non-B hepatitis (NANB) died in Government Medical College Hospital, Aurangabad. Serum samples from these patients were tested for antibodies to hepatitis C virus (anti-HCV) and IgM antibodies to hepatitis E virus (IgM-anti-HEV). All samples were also subjected to polymerase chain reaction (PCR) for the detection of HBV DNA, HCV RNA and HEV RNA. None of the patients had circulating anti-HCV antibodies; three had HCV RNA. Based on anti-HEV-IgM positivity 14 patients (37%) could be diagnosed as suffering from hepatitis E. None was positive for HEV RNA. In the absence of serological markers, HBV DNA was present in three cases. None of the HBV DNA positive patients had anti-δ antibodies. Dual infections (HBV with HEV, and HBV with HCV) were seen in two cases. The aetiology of half of the NANB cases could not be assigned to the known hepatitis viruses using current techniques. 相似文献
133.
Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status 总被引:7,自引:0,他引:7
Goswami R Dadhwal V Tejaswi S Datta K Paul A Haricharan RN Banerjee U Kochupillai NP 《The Journal of infection》2000,41(2):162-166
OBJECTIVES: Non- C. albicans Candida species are increasingly being recognized as the cause of vulvo-vaginal candidiasis. These species are often less susceptible to antifungal agents. Patients with diabetes mellitus are at risk for vulvo-vaginal candidasis. We assessed the species-specific prevalence rate and risk of candidiasis in patients with diabetes mellitus and healthy controls. METHODS: Genital tract examination, direct microscopy and fungal cultures of discharge collected by high vaginal swab were undertaken among 78 consecutive patients with diabetes mellitus (mean (+/-sd) age 32+/-12 years and body mass index (BMI) 22.3+/-5.5kg/m(2)) and 88 age- and BMI-matched healthy females. Glycaemic control in the diabetic cohort was assessed by measuring total glycosylated haemoglobin. RESULTS: Candida species were isolated in 36 of 78 (46%) subjects with diabetes mellitus and in 21 of 88 (23%) healthy subjects (Chi-squared 9.11, P=0.0025). The predominant Candida species isolated in diabetics with vulvo-vaginal candidiasis were Candida glabrata (39%), C. albicans (26%) and C. tropicalis (17%). In contrast, in the control group, C. albicans, C. glabrata and C. hemulonii comprised 30% each, with none having C. tropicalis infection (for C. tropicalis: diabetic vs. control; 17% vs. nil, P=0. 05). Among the diabetic group, subjects with vulvo-vaginal candidiasis had significantly higher mean HbA1 when compared to those who had no such infection (12.8+/-2.6% vs. 9.7+/-1.7% respectively, P=0.001). The overall accuracy of direct microscopy and clinical examination for predicting vulvo-vaginal candidiasis was only 77% and 51%, respectively, in the diabetic group, and 83% and 65% in the control group. CONCLUSIONS: Patients with diabetes mellitus had a high prevalence rate (46%) of vulvo-vaginal candidiasis with relative risk of 2.45. The non- C. albicans species such as C. glabrata and C. tropicalis were the predominant species isolated among them. There seems to be a significant link between hyperglycaemia and vulvo-vaginal candidiasis. 相似文献
134.
135.
136.
137.
Thomson KJ Hart DP Banerjee L Ward KN Peggs KS Mackinnon S 《Bone marrow transplantation》2005,35(11):1065-1069
Patients undergoing haemopoietic stem cell transplants (HSCT) are at high risk of varicella zoster virus (VZV) reactivation, with a significant incidence of dissemination. This study reports a retrospective analysis of 247 allogeneic HSCT recipients receiving anti-viral prophylaxis with low-dose oral aciclovir 400 mg/day, administered until immunosuppression was discontinued and the CD4(+) cell count exceeded 200/mm(3). Viral reactivation was successfully suppressed by aciclovir prophylaxis, with only one case of breakthrough infection. The cumulative incidence of zoster infection at 1 year post transplant was 2% and at 5 years 34%. In all, 64 patients discontinued prophylaxis. Zoster developed in 26 of these, giving a cumulative incidence of infection at 1 year after stopping aciclovir of 39% and at 3 years 44%. Infection occurred in a localised dermatomal distribution in 93% of cases. This supports previous findings that aciclovir prophylaxis prevents early VZV reactivation, although the long-term incidence is not affected as infection occurs once prophylaxis is discontinued. Such infection, however, is mild and localised. This study does not support the idea that use of such low-dose aciclovir regimens reduces the zoster incidence by permitting subclinical reactivation during prophylaxis, and therefore the re-establishment of protective anti-viral immunity. 相似文献
138.
139.
I. Annesi‐Maesano C. Zhou N. Baïz S. Banerjee D. Andr Charpin D. Caillaud F. de Blay C. Raherison F. Lavaud 《Allergy》2013,68(11):1471-1474
We investigated the relationships of behavioural problems as assessed using the standardized Strengths and Difficulties Questionnaire (SDQ) to asthma in view of improving asthma management. Six thousand eight hundred and eighty children (mean age 10.4 years, male: 49%) were recruited in the French 6 Cities Study. Children with abnormal or borderline emotional symptoms (internalizing problems) or conduct problems (externalizing problems) were more asthmatic than others (P < 0.01). Compared to being normal, abnormal emotional symptoms or conduct problems were found to be related to mild‐to‐moderate persistent asthma (logistic model adjusted odds ratio = 1.55 (95% CI = 1.26–1.90) and 1.42 (95% CI = 1.17–1.71), respectively) and to early‐onset asthma (Cox's model Adjusted Hazard Risk = 1.60 (95% CI = 1.27–2.01) and 1.34 (95% CI = 1.05–1.70). Borderline conduct problems were found to be negatively related to parents' knowledge on how to prevent asthma attacks, compared to normal conduct problems [adjusted OR = 0.51 (95% CI = 0.31–0.85)]. Further data are needed to better understand the involvement of behavioural problems in childhood asthma according to phenotypes. 相似文献
140.
Alastair J. Flint Anthony J. Rothschild Ellen M. Whyte George S. Alexopoulos Benoit H. Mulsant Patricia Marino Samprit Banerjee Cristina D. Pollari Yiyuan Wu Aristotle N. Voineskos Barnett S. Meyers 《The American journal of geriatric psychiatry》2021,29(7):645-654
ObjectiveTo examine the effect of older versus younger age on change in anthropometric and metabolic measures during extended treatment of psychotic depression with sertraline plus olanzapine.MethodsTwo hundred and sixty-nine men and women aged 18–85 years with an episode of psychotic depression were treated with open-label sertraline plus olanzapine for up to 12 weeks. Participants who remained in remission following an 8-week stabilization phase were eligible to participate in a 36-week randomized controlled trial (RCT) that compared the efficacy and tolerability of sertraline plus olanzapine with sertraline plus placebo. Weight, waist circumference and plasma lipids, glucose, HbA1c, and insulin were measured at regular intervals during the acute, stabilization and randomized phases of the study. Linear mixed models were used to analyze the trajectories of anthropometric and metabolic measures.ResultsParticipants aged 60 years or older experienced less weight gain and less increase in cholesterol during the combined acute and stabilization phases of the study compared with those aged 18–59 years. At the acute-stabilization termination visit, mean weight in older participants was 6.5 lb. less than premorbid weight, whereas it was 17.9 lb. more than premorbid weight in younger participants. In the RCT, there was a significant interaction of treatment and age group for the trajectory of weight, but the post hoc tests that compared age groups within each treatment arm were not statistically significant. There were no clinically significant differences between younger and older participants in glycemic measures.ConclusionOlder patients with psychotic depression experienced less increase in weight and total cholesterol than their younger counterparts during acute and stabilization treatment with sertraline plus olanzapine. In the older group, weight gained during the acute and stabilization phases appeared to be partial restoration of weight lost during the index episode of depression, whereas weight gain in younger participants was not. 相似文献